Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 59 Official measures

1 The FOPH may re­voke or sus­pend the au­thor­isa­tion gran­ted or make the con­tinu­ation of the clin­ic­al tri­al sub­ject to ad­di­tion­al con­di­tions, par­tic­u­larly if:

a.
it has reas­on to as­sume that the re­quire­ments are no longer met, the doc­u­ments spe­cified in Art­icle 54 have been changed without due no­ti­fic­a­tion hav­ing been made, or the tri­al is not be­ing con­duc­ted in ac­cord­ance with these doc­u­ments;
b.
such meas­ures are ne­ces­sit­ated by new in­form­a­tion con­cern­ing safety or the sci­entif­ic basis.

2 For the co­ordin­a­tion of meas­ures and the ex­change of in­form­a­tion between the FOPH, the re­spons­ible eth­ics com­mit­tee and oth­er com­pet­ent can­ton­al au­thor­it­ies, Art­icle 48 ap­plies mu­tatis mutandis.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden